Advent to acquire controlling stake in RA Chem Pharma at $133m valuation

Advent to acquire controlling stake in RA Chem Pharma at $133m valuation

Photo: Reuters

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter